Sign in
4

Changes in Ownership

Edgewise Therapeutics, Inc. Filed Acc 0001562180-24-005018

Options or other derivatives

  • Director acquired 20,594 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Edris Badreddin Director 2024-06-10 Grant or award · Stock Option (Right to Buy) +20,594 20,594 D
Loading xslF345X05/primarydocument.xml…